cro.directory
← Compare landing

ExperTrials vs ProRelix Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/expertrials/prorelixresearch

CategoryExperTrialsProRelix Research
Listed sitecrocro
SummaryEuropean-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.
Services
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Device & Combination Product Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Oncology
  • Infectious Disease
  • Gastroenterology
  • Cardiovascular
  • Neurology
  • Rare Disease
Data not yet provided.
Locations
  • Headquarters, Lyon, France
  • US Office, Pennsylvania, Pennsylvania, USA
  • United States, US, United States
  • India, India, India
  • Europe, Europe, Europe
  • Australia, Australia, Australia
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.